Sugammadex and the Risk of Unintended Pregnancy in Women With Vascular Anomalies, An Alert for the Team

Journal of Vascular Anomalies 2026 Open access

Read full text
Authors: Charlotte Thirion, Marie-Agnès Docquier, Julien Coulie, Stanislas Smajda, Frank Hammer, Laurence M. Boon, Emmanuel Seront
DOI: 10.1097/jova.0000000000000138
Cited by: 0
References: 13

Abstract

This article highlights a clinically relevant and under-recognized issue: the potential interaction between sugammadex, an increasingly used anesthesia medication, and hormonal contraceptives in women with vascular anomalies receiving teratogenic therapies. With many of these women undergoing repeated procedures under general anesthesia and concurrently receiving agents such as sirolimus or thalidomide, there is a pressing need for heightened awareness around contraceptive efficacy and risk mitigation.

Fields of Study & Subjects

Reproductive Health and Contraception Anesthesia and Sedative Agents Pregnancy and Medication Impact

Publication details

Journal / source
Journal of Vascular Anomalies
Volume
7
Issue
1
Pages
e138–e138
Publication date
1 March 2026
Language
EN